BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,050,943 | -7.1% | 54,344 | +12.2% | 0.02% | 0.0% |
| Q2 2023 | $2,206,835 | -1.7% | 48,438 | -12.5% | 0.02% | -6.2% |
| Q1 2023 | $2,244,509 | -29.5% | 55,338 | -11.4% | 0.02% | -33.3% |
| Q4 2022 | $3,182,465 | +109715.9% | 62,438 | +16.0% | 0.02% | 0.0% |
| Q3 2022 | $2,898 | -99.9% | 53,803 | +11.1% | 0.02% | -7.7% |
| Q2 2022 | $3,111,000 | -42.7% | 48,433 | -30.8% | 0.03% | -21.2% |
| Q1 2022 | $5,429,000 | -24.3% | 70,021 | -16.2% | 0.03% | -15.4% |
| Q4 2021 | $7,172,000 | -68.6% | 83,551 | -70.6% | 0.04% | -70.2% |
| Q3 2021 | $22,868,000 | +260.4% | 284,321 | +260.7% | 0.13% | +244.7% |
| Q2 2021 | $6,346,000 | +57.5% | 78,831 | +65.0% | 0.04% | +46.2% |
| Q1 2021 | $4,029,000 | -87.6% | 47,771 | -88.2% | 0.03% | -89.5% |
| Q4 2020 | $32,362,000 | +22.9% | 403,321 | +23.2% | 0.25% | +15.4% |
| Q3 2020 | $26,337,000 | +26.1% | 327,491 | +35.0% | 0.21% | +10.3% |
| Q2 2020 | $20,885,000 | +403.7% | 242,571 | +375.0% | 0.19% | +304.2% |
| Q1 2020 | $4,146,000 | -43.8% | 51,071 | -42.1% | 0.05% | +4.3% |
| Q4 2019 | $7,376,000 | -14.9% | 88,211 | -11.0% | 0.05% | -20.7% |
| Q3 2019 | $8,670,000 | +70.8% | 99,121 | +60.0% | 0.06% | +41.5% |
| Q2 2019 | $5,075,000 | +56.9% | 61,969 | +55.8% | 0.04% | +41.4% |
| Q1 2019 | $3,234,000 | -8.3% | 39,769 | -25.8% | 0.03% | -3.3% |
| Q4 2018 | $3,526,000 | -89.7% | 53,569 | -87.9% | 0.03% | -87.4% |
| Q3 2018 | $34,106,000 | +3.3% | 442,416 | -1.0% | 0.24% | +6.7% |
| Q2 2018 | $33,006,000 | +69.8% | 447,000 | +49.6% | 0.22% | +64.7% |
| Q1 2018 | $19,438,000 | +717.8% | 298,864 | +712.8% | 0.14% | +806.7% |
| Q4 2017 | $2,377,000 | -86.2% | 36,769 | -86.6% | 0.02% | -79.7% |
| Q3 2017 | $17,179,000 | +416.5% | 273,769 | +398.2% | 0.07% | +164.3% |
| Q2 2017 | $3,326,000 | -42.3% | 54,947 | -50.6% | 0.03% | -46.2% |
| Q1 2017 | $5,764,000 | +20.8% | 111,147 | +3.3% | 0.05% | +10.6% |
| Q4 2016 | $4,773,000 | -8.6% | 107,647 | -1.9% | 0.05% | -14.5% |
| Q3 2016 | $5,224,000 | +10.4% | 109,747 | +4.9% | 0.06% | +5.8% |
| Q2 2016 | $4,732,000 | +30.8% | 104,647 | +18.9% | 0.05% | +30.0% |
| Q1 2016 | $3,617,000 | -32.1% | 88,047 | -37.0% | 0.04% | -7.0% |
| Q4 2015 | $5,328,000 | +12.8% | 139,647 | -2.9% | 0.04% | +2.4% |
| Q3 2015 | $4,722,000 | -64.0% | 143,747 | -23.3% | 0.04% | -55.8% |
| Q2 2015 | $13,101,000 | +1.8% | 187,347 | -0.3% | 0.10% | 0.0% |
| Q1 2015 | $12,868,000 | -4.3% | 187,847 | +2.4% | 0.10% | +9.2% |
| Q4 2014 | $13,449,000 | -6.3% | 183,499 | -8.2% | 0.09% | -7.4% |
| Q3 2014 | $14,347,000 | -2.9% | 199,899 | -2.2% | 0.09% | +5.6% |
| Q2 2014 | $14,771,000 | +1.0% | 204,299 | +2.7% | 0.09% | -5.3% |
| Q1 2014 | $14,631,000 | +4.1% | 198,841 | -1.6% | 0.09% | +8.0% |
| Q4 2013 | $14,059,000 | +18.3% | 202,141 | +11.7% | 0.09% | +19.2% |
| Q3 2013 | $11,886,000 | -8.0% | 180,941 | -2.9% | 0.07% | -27.7% |
| Q2 2013 | $12,915,000 | – | 186,441 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |